Avantor Performance Materials, Inc.

27 articles with Avantor Performance Materials, Inc.

• Avantor® to Host Virtual Investor Day

  8/30/2021

  Avantor, Inc. announced that it will host a virtual investor day on September 9, 2021 starting at 9:00 a.m. Eastern Daylight Time .

• Avantor® Announces Date Change for Second Quarter 2021 Earnings Release and Conference Call

  7/16/2021

  Avantor, Inc. today announced that it has changed the date of its previously announced earnings release and conference call. The Company will now release its financial results for the second quarter 2021 after the market closes on Thursday, July 29, 2021, and will hold a conference call on Friday, July 30, 2021 to discuss the results at 7:30 a.m. Eastern Daylight Time.

• Avantor® to Acquire Ritter GmbH and its Affiliates; Expands Proprietary Offering for Diagnostic and Drug Discovery Workflows

  4/12/2021

  - Ritter is a fast-growing, technology leader in high-precision consumables - Combines Ritter's liquid handling consumables platform for clinical diagnostic testing and life sciences research with Avantor's offerings for critical lab automation workflows and leading global customer channel

• Avantor® to Participate at the Raymond James 42nd Annual Institutional Investor Conference

  2/22/2021

   Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the Raymond James 42nd Annual Institutional Investor Conference on Monday, March 1 , 2021.

• Avantor® Reports Fourth Quarter and Full-Year 2020 Results

  2/3/2021

  Business Highlights - Q4 revenue of $1.791 billion, up 17.5%; organic revenue growth of 14.9% - Q4 Adjusted EBITDA $319.9 million, expansion of 60 basis points - Q4 EPS of $0.06; adjusted EPS of $0.29, growth of 57.2% - Q4 operating cash flow $306 million; free cash flow $286 million, growth of 282%   [03-February-2021]

• Avantor® to Report Fourth Quarter and Full Year 2020 Earnings and Host Earnings Call on Wednesday, February 3, 2021

  1/11/2021

  Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the fourth quarter and full year 2020 after the market closes on Wednesday, February 3

• Avantor® to Present at the 39th Annual J.P. Morgan Healthcare Conference

  12/14/2020

   Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, will participate in the 39th Annual J.P. Morgan Healthcare Conference being held virtually on Monday, January 11 , 2021. Michael Stubblefield, Pres

• Avantor® Announces Secondary Offering of 71,339,001 Shares of Common Stock

  11/4/2020

  Avantor, Inc. announced that certain of its stockholders, including an affiliate of New Mountain Capital, LLC, intend to offer for sale in an underwritten secondary offering 71,339,001 shares of common stock of the Company pursuant to a registration statement filed by the Company with the U.S. Securities and Exchange Commission.

• Avantor® Discusses Cell & Gene Therapy Production Trends Through the Lens of COVID-19

  11/2/2020

  Avantor executives joined other industry leaders at virtual Cell & Gene Therapy Bioprocessing & Commercialization Conference Panels discussed critical topics including process efficiency and scaling solutions

• Avantor® Announces Offering of Senior First Lien Notes

  10/28/2020

   Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today the commencement of a private offering of euro-denominated senior first lien notes (the "Notes") to be issued by its whol

• Avantor® Announces Preliminary Third Quarter Unaudited Revenues

  10/23/2020

  - Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, provided preliminary unaudited revenue estimates for the third quarter ended September 30, 2020 , in conjunction with proposed debt refinancing tran

• Avantor® to Report Third Quarter Earnings and Host Earnings Call on Wednesday, October 28, 2020

  10/2/2020

  Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the third quarter 2020 after the market closes on Wednesday, October 28, 2020 , and

• Avantor® to Present at the 2020 Wells Fargo Virtual Healthcare Conference

  8/31/2020

  Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in the 2020 Wells Fargo Virtual Healthcare Conference on Thursday, September 10 , 2020. Michael Stubblefield, President and CEO

• Avantor Announces Credit Rating Upgrade by Fitch Ratings

  5/22/2020

  Fitch upgrades the company's long-term issuer default rating to BB-/Stable Company's strong operating performance, portfolio management and strong competitive position cited as reasons for the upgrade   [22-May-2020]   RADNOR, Pa. , May 22, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical

• Avantor to Present at the Virtual Bank of America Securities 2020 Healthcare Conference

  5/6/2020

   Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in the Bank of America Securities 2020 Healthcare Conference, taking place virtually on Tuesday, May 12. Avantor's presentation is sc

• Avantor® Launches New Protein A Chromatography Resin - PROchievA - that Provides Supply Chain Flexibility and Improves Downstream Purification Performance for Monoclonal Antibodies (mAbs) Production

  3/18/2020

  New high purity resin advances bioprocessing and brings choice and efficiencies to mAbs production workflow processes and protocols

• Avantor® to Report Second Quarter Earnings and Host Earnings Call on Tuesday, August 6

  7/23/2019

  Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life science and advanced technologies & applied materials industries, announced today that it will release its financial results for the second quarter of 2019 on Tuesday, August 6 and will hold a conference call to discuss the results at 8:30 am EDT.

• Avantor® Announces Pricing of Initial Public Offering and Concurrent Offering of Mandatory Convertible Preferred Stock

  5/17/2019

  Avantor, Inc. announced that it has priced the initial public offering of 207,000,000 shares of its common stock at a price to the public of $14.00 per share and a concurrent public offering of 18,000,000 shares of its 6.250% Series A Mandatory Convertible Preferred Stock at a price to the public of $50.00 per share.

• Avantor Completes Acquisition of VWR

  11/21/2017

  VWR will operate as a wholly-owned subsidiary of Avantor.

• Chemical Company Avantor Performance Materials, Inc. to Cut 150 Jobs

  1/9/2015